Oct 10 (Reuters) - Kalytera Therapeutics Inc KALY.V -
* Kalytera Therapeutics, Inc. announces Robert Farrell, J.D. as CEO; additional board and management changes
* Kalytera Therapeutics- Pini Ben-Elazar, who served as a member of company's board since March 2017, has submitted his resignation from board
* Company has accepted resignation of Mr. David Bassa, who served as company's chief operating officer